Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilar Testing and Development Services market report explains the definition, types, applications, major countries, and major players of the Biosimilar Testing and Development Services market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
SGS
Intertek Group
Pharmaceutical Product Development
Source BioScience
Medistri
Exova
Sigma-Aldrich
Pace Analytical Services
Charles River Laboratories
Eurofins Scientific
By Type:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
By End-User:
PK assay
Tiered Immunogenicity testing
NAb assays
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biosimilar Testing and Development Services Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biosimilar Testing and Development Services Outlook to 2028- Original Forecasts
-
2.2 Biosimilar Testing and Development Services Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biosimilar Testing and Development Services Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biosimilar Testing and Development Services Market- Recent Developments
-
6.1 Biosimilar Testing and Development Services Market News and Developments
-
6.2 Biosimilar Testing and Development Services Market Deals Landscape
7 Biosimilar Testing and Development Services Raw Materials and Cost Structure Analysis
-
7.1 Biosimilar Testing and Development Services Key Raw Materials
-
7.2 Biosimilar Testing and Development Services Price Trend of Key Raw Materials
-
7.3 Biosimilar Testing and Development Services Key Suppliers of Raw Materials
-
7.4 Biosimilar Testing and Development Services Market Concentration Rate of Raw Materials
-
7.5 Biosimilar Testing and Development Services Cost Structure Analysis
-
7.5.1 Biosimilar Testing and Development Services Raw Materials Analysis
-
7.5.2 Biosimilar Testing and Development Services Labor Cost Analysis
-
7.5.3 Biosimilar Testing and Development Services Manufacturing Expenses Analysis
8 Global Biosimilar Testing and Development Services Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biosimilar Testing and Development Services Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biosimilar Testing and Development Services Export by Region (Top 10 Countries) (2017-2028)
9 Global Biosimilar Testing and Development Services Market Outlook by Types and Applications to 2022
-
9.1 Global Biosimilar Testing and Development Services Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Effector Binding Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ELISA Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Kinetic Binding Assays Consumption and Growth Rate (2017-2022)
-
9.1.4 Global ADCC & CDC Cell-Based Assays Consumption and Growth Rate (2017-2022)
-
9.2 Global Biosimilar Testing and Development Services Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global PK assay Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Tiered Immunogenicity testing Consumption and Growth Rate (2017-2022)
-
9.2.3 Global NAb assays Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biosimilar Testing and Development Services Market Analysis and Outlook till 2022
-
10.1 Global Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.2.2 Canada Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.2.3 Mexico Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.2 UK Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.3 Spain Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.4 Belgium Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.5 France Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.6 Italy Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.7 Denmark Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.8 Finland Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.9 Norway Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.10 Sweden Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.11 Poland Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.12 Russia Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.3.13 Turkey Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.2 Japan Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.3 India Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.4 South Korea Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.5 Pakistan Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.6 Bangladesh Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.7 Indonesia Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.8 Thailand Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.9 Singapore Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.10 Malaysia Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.11 Philippines Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.4.12 Vietnam Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.2 Colombia Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.3 Chile Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.4 Argentina Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.5 Venezuela Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.6 Peru Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.7 Puerto Rico Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.5.8 Ecuador Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.6.2 Kuwait Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.6.3 Oman Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.6.4 Qatar Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.7.2 South Africa Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.7.3 Egypt Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.7.4 Algeria Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biosimilar Testing and Development Services Consumption (2017-2022)
-
10.8.2 New Zealand Biosimilar Testing and Development Services Consumption (2017-2022)
11 Global Biosimilar Testing and Development Services Competitive Analysis
-
11.1 SGS
-
11.1.1 SGS Company Details
-
11.1.2 SGS Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 SGS Biosimilar Testing and Development Services Main Business and Markets Served
-
11.1.4 SGS Biosimilar Testing and Development Services Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Intertek Group
-
11.2.1 Intertek Group Company Details
-
11.2.2 Intertek Group Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Intertek Group Biosimilar Testing and Development Services Main Business and Markets Served
-
11.2.4 Intertek Group Biosimilar Testing and Development Services Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pharmaceutical Product Development
-
11.3.1 Pharmaceutical Product Development Company Details
-
11.3.2 Pharmaceutical Product Development Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Main Business and Markets Served
-
11.3.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Source BioScience
-
11.4.1 Source BioScience Company Details
-
11.4.2 Source BioScience Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Source BioScience Biosimilar Testing and Development Services Main Business and Markets Served
-
11.4.4 Source BioScience Biosimilar Testing and Development Services Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Medistri
-
11.5.1 Medistri Company Details
-
11.5.2 Medistri Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Medistri Biosimilar Testing and Development Services Main Business and Markets Served
-
11.5.4 Medistri Biosimilar Testing and Development Services Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Exova
-
11.6.1 Exova Company Details
-
11.6.2 Exova Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Exova Biosimilar Testing and Development Services Main Business and Markets Served
-
11.6.4 Exova Biosimilar Testing and Development Services Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sigma-Aldrich
-
11.7.1 Sigma-Aldrich Company Details
-
11.7.2 Sigma-Aldrich Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sigma-Aldrich Biosimilar Testing and Development Services Main Business and Markets Served
-
11.7.4 Sigma-Aldrich Biosimilar Testing and Development Services Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pace Analytical Services
-
11.8.1 Pace Analytical Services Company Details
-
11.8.2 Pace Analytical Services Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pace Analytical Services Biosimilar Testing and Development Services Main Business and Markets Served
-
11.8.4 Pace Analytical Services Biosimilar Testing and Development Services Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Charles River Laboratories
-
11.9.1 Charles River Laboratories Company Details
-
11.9.2 Charles River Laboratories Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Charles River Laboratories Biosimilar Testing and Development Services Main Business and Markets Served
-
11.9.4 Charles River Laboratories Biosimilar Testing and Development Services Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Eurofins Scientific
-
11.10.1 Eurofins Scientific Company Details
-
11.10.2 Eurofins Scientific Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Eurofins Scientific Biosimilar Testing and Development Services Main Business and Markets Served
-
11.10.4 Eurofins Scientific Biosimilar Testing and Development Services Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Biosimilar Testing and Development Services Market Outlook by Types and Applications to 2028
-
12.1 Global Biosimilar Testing and Development Services Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Effector Binding Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global ELISA Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Kinetic Binding Assays Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global ADCC & CDC Cell-Based Assays Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biosimilar Testing and Development Services Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global PK assay Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Tiered Immunogenicity testing Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global NAb assays Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biosimilar Testing and Development Services Market Analysis and Outlook to 2028
-
13.1 Global Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.2.2 Canada Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.2 UK Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.3 Spain Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.5 France Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.6 Italy Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.8 Finland Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.9 Norway Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.11 Poland Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.12 Russia Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.2 Japan Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.3 India Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.3 Chile Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.6 Peru Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.6.3 Oman Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biosimilar Testing and Development Services Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biosimilar Testing and Development Services
-
Figure of Biosimilar Testing and Development Services Picture
-
Table Global Biosimilar Testing and Development Services Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biosimilar Testing and Development Services Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Effector Binding Consumption and Growth Rate (2017-2022)
-
Figure Global ELISA Consumption and Growth Rate (2017-2022)
-
Figure Global Kinetic Binding Assays Consumption and Growth Rate (2017-2022)
-
Figure Global ADCC & CDC Cell-Based Assays Consumption and Growth Rate (2017-2022)
-
Figure Global PK assay Consumption and Growth Rate (2017-2022)
-
Figure Global Tiered Immunogenicity testing Consumption and Growth Rate (2017-2022)
-
Figure Global NAb assays Consumption and Growth Rate (2017-2022)
-
Figure Global Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Table North America Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure United States Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Canada Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table Europe Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure Germany Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure UK Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Spain Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure France Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Italy Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Finland Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Norway Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Poland Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Russia Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table APAC Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure China Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Japan Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure India Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table South America Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure Brazil Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Chile Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Peru Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table GCC Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure Bahrain Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Oman Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table Africa Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure Nigeria Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table Oceania Biosimilar Testing and Development Services Consumption by Country (2017-2022)
-
Figure Australia Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biosimilar Testing and Development Services Consumption and Growth Rate (2017-2022)
-
Table SGS Company Details
-
Table SGS Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table SGS Biosimilar Testing and Development Services Main Business and Markets Served
-
Table SGS Biosimilar Testing and Development Services Product Portfolio
-
Table Intertek Group Company Details
-
Table Intertek Group Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intertek Group Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Intertek Group Biosimilar Testing and Development Services Product Portfolio
-
Table Pharmaceutical Product Development Company Details
-
Table Pharmaceutical Product Development Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmaceutical Product Development Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Pharmaceutical Product Development Biosimilar Testing and Development Services Product Portfolio
-
Table Source BioScience Company Details
-
Table Source BioScience Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Source BioScience Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Source BioScience Biosimilar Testing and Development Services Product Portfolio
-
Table Medistri Company Details
-
Table Medistri Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medistri Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Medistri Biosimilar Testing and Development Services Product Portfolio
-
Table Exova Company Details
-
Table Exova Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exova Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Exova Biosimilar Testing and Development Services Product Portfolio
-
Table Sigma-Aldrich Company Details
-
Table Sigma-Aldrich Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma-Aldrich Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Sigma-Aldrich Biosimilar Testing and Development Services Product Portfolio
-
Table Pace Analytical Services Company Details
-
Table Pace Analytical Services Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pace Analytical Services Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Pace Analytical Services Biosimilar Testing and Development Services Product Portfolio
-
Table Charles River Laboratories Company Details
-
Table Charles River Laboratories Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Charles River Laboratories Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Charles River Laboratories Biosimilar Testing and Development Services Product Portfolio
-
Table Eurofins Scientific Company Details
-
Table Eurofins Scientific Biosimilar Testing and Development Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eurofins Scientific Biosimilar Testing and Development Services Main Business and Markets Served
-
Table Eurofins Scientific Biosimilar Testing and Development Services Product Portfolio
-
Figure Global Effector Binding Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ELISA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kinetic Binding Assays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ADCC & CDC Cell-Based Assays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PK assay Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tiered Immunogenicity testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NAb assays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Table North America Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure United States Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure Germany Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure China Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biosimilar Testing and Development Services Consumption Forecast by Country (2022-2028)
-
Figure Australia Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biosimilar Testing and Development Services Consumption Forecast and Growth Rate (2022-2028)
-
